• compare Vidaza side effects Compare Vidaza Side Effects
  • Search More FDA reports:

Help Community - Describe Your Vidaza Side Effect
Have You experienced Vidaza Side Effects?
Yes, Severe
Yes, Moderate
Yes, Minor
No
Read Community Posts


Compare Vidaza Side Effects   Post Your Vidaza Side Effect and Help Community!   List of Vidaza Side Effects reported to Patientsville   Detailed Vidaza Side Effects reported to Patientsville   Vidaza Side Effects reported to FDA   Quick-Add Your Side Effect   Substances toxic to Health   Side Effects Survey

Vidaza Side Effects summary

Total Vidaza reports: 146.
Vidaza FDA safety alerts: No.
Reported deaths: 55    Reported hospitalizations: 112.
How to use Vidaza ?.
Ask a Health Expert about Vidaza or Ask Patient Community about Vidaza.

Post a question or leave a comment:

Comments to date: 1. Page 1 of 1.

John P.   Location unknown

8:33pm on Tuesday, September 23rd, 2008

My 73 yo mother was diagnosed with myelodysplasia three months ago. After failing to respond to the growth factor treatment, her doctor began administering Vidaza, using the 5 day cycle. After the 3rd shot, she was treated for dehydration. After the ... read more »

Add Your Comment

Vidaza Poll Results

Have you experienced Vidaza side effects?
Yes, Severe67%
Yes, Mild33%
Yes, Minor0%
No0%
Post Your Vidaza Side Effect and Help Community!

Recent Questions and Answers about Vidaza

Is 'azacytidine' sold as medicine for cancer treatment?

Vidaza Side Effects reported on Patientsville.com

None reported at this time.

Vidaza FDA reported side effects and reactions

2008
ABDOMINAL PAIN
2007
ANAEMIA, ATRIAL FIBRILLATION
2006

Vidaza Side Effects reported to FDA


Quick-Add Your Side Effect:

Showing 1-40 of 146 Next >

Vidaza Side Effects Report #5207122-6
Consumer or non-health professional from UNITED STATES reported VIDAZA problem on Dec 27, 2006. Female patient, 86 years of age, weighting 126.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: chest pain What is  chest pain, gastrooesophageal reflux disease. VIDAZA dosage: unknown. During the same period patient was treated with VERAPAMIL, PREDNISONE. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5213880-7
VIDAZA problem was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation What is  atrial fibrillation, culture urine positive, enterococcal infection, neutropenic sepsis, no therapeutic response, pericardial effusion, pericarditis, sinus tachycardia, staphylococcal infection. VIDAZA dosage: 132.75 MG (75 MG/M2, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL. Patient was hospitalized. Patient died on 01/08/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5225220-8
Consumer or non-health professional from PHILIPPINES reported VIDAZA problem on Jan 23, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: arrhythmia What is  arrhythmia. VIDAZA dosage: unknown. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5228738-7
VIDAZA problem was reported by a Physician from UNITED STATES on Jan 19, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation What is  atrial fibrillation, cardiopulmonary failure, culture urine positive, enterococcal infection, hypotension, neutropenic sepsis, no therapeutic response, pericarditis, sinus tachycardia. VIDAZA dosage: 132.75 MG (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/08/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More



Vidaza Side Effects Report #5229612-2
Physician from UNITED STATES reported VIDAZA problem on Jan 18, 2007. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: coma, dialysis What is  dialysis, haemoglobin decreased, haemorrhage, hypotension, leukopenia, pneumonia What is  pneumonia. VIDAZA dosage: 75 MG/M2 (130 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with COUMADIN, LIPITOR, DIGITEX, ATACAND, ARANESP. Patient was hospitalized. Patient died on 02/16/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5237948-4
VIDAZA problem was reported by a Physician from PHILIPPINES on Feb 01, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, arrhythmia What is  arrhythmia, asthenia, disease progression, platelet count decreased. VIDAZA dosage: 50 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5241458-8
Physician from UNITED STATES reported VIDAZA problem on Jan 26, 2007. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: fungal infection, lung neoplasm, pulmonary embolism What is  pulmonary embolism. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5286019-X
VIDAZA problem was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis What is  sepsis, sputum discoloured, sputum purulent. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5293978-8
Physician from UNITED STATES reported VIDAZA problem on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, fungal infection, hepatic infection, lung neoplasm, pulmonary embolism What is  pulmonary embolism. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More



Vidaza Side Effects Report #5343436-7
VIDAZA problem was reported by a Physician from UNITED KINGDOM on May 17, 2007. Male patient, 55 years of age, weighting 188.7 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure systolic decreased, condition aggravated, neutropenic sepsis, pseudomonas infection, refusal of treatment by patient, sputum culture positive, white blood cell count decreased. VIDAZA dosage: 75 MG/M2 (150 MG ONCE DAILY X FIVE DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, ATRA, VALACYCLOVIR, METRONIDAZOLE, ADCORTYL IN ORAL BASE, AMILORIDE. Patient was hospitalized. Patient died on 05/09/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5354898-3
Physician from UNITED STATES reported VIDAZA problem on June 04, 2007. Male patient, 79 years of age, weighting 199.1 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood potassium decreased, crepitations, decreased appetite, discomfort, dyspnoea exertional, fatigue. VIDAZA dosage: 50 MG/M2 (DAYS 1 THROUGH 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with LASIX, COLACE, SENOKOT, NEURONTIN, PENICILLIN. Patient died on 04/26/2007.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5367782-6
VIDAZA problem was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, haemolysis, nausea, polychromasia, red blood cell spherocytes present. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5049253-X
Pharmacist from UNITED STATES reported VIDAZA problem on June 26, 2006. Male patient was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: splenic rupture, splenomegaly. VIDAZA dosage: unknown. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5060546-2
VIDAZA problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, haemorrhage, pneumonia What is  pneumonia, sepsis What is  sepsis. VIDAZA dosage: unknown. During the same period patient was treated with LIPITOR, ATIVAN. Patient was hospitalized. Patient died on 02/16/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More



Vidaza Side Effects Report #5071698-2
Physician from UNITED STATES reported VIDAZA problem on July 27, 2006. Male patient, 58 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: colitis, ileus, intestinal obstruction, pancreatitis. VIDAZA dosage: 75 MG/M2 (140 MG) SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, PROCHLORPERAZINE MALEATE, IPRATROPIUM. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5077823-1
VIDAZA problem was reported by a Physician from UNITED STATES on July 24, 2006. Female patient, 61 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: gastric perforation, septic shock. VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with METOPROLOL. Patient was hospitalized. Patient died on 07/11/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5084852-0
Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF reported VIDAZA problem on Aug 03, 2006. Female patient, 74 years of age, weighting 101.4 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, epistaxis, febrile neutropenia, hyponatraemia, meningitis bacterial, pancytopenia, pneumonia What is  pneumonia. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FOSAMAX. Patient was hospitalized. Patient died on 05/14/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5097684-4
VIDAZA problem was reported by a Physician from THAILAND on Aug 24, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: infection, nausea, neutropenia, vomiting. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5120147-4
Physician from THAILAND reported VIDAZA problem on Sept 14, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haematocrit decreased, lobar pneumonia, lymphocyte percentage increased, nausea, neutropenia, platelet count decreased, septic shock. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More



Vidaza Side Effects Report #5128618-1
VIDAZA problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Male patient, 51 years of age, weighting 244.9 lb, was diagnosed with metastatic malignant melanoma and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: arthropod sting, iritis, local swelling. VIDAZA dosage: 75 MG/M2 (DAILY X 3 DAYS EVERY 2 WEEKS), SUBCUTANEOUS. During the same period patient was treated with INTERFERON, AMBIEN CR, FERROUS SULPHATE, PERCOCET, SYNTHROID. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5144297-1
Consumer or non-health professional from UNITED STATES reported VIDAZA problem on Oct 18, 2006. Female patient, 71 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, caecitis, vomiting. VIDAZA dosage: unknown. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5145543-0
VIDAZA problem was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 79 years of age, weighting 183.4 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, dilatation atrial, epistaxis, thrombocytopenia, ventricular extrasystoles, ventricular hypertrophy. VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, SPIRIVA, ADVAIR DISKUS, FLONASE, ALLEGRA, ZOLOFT, FOLATE, METAMUCIL. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5146393-1
Physician from UNITED STATES reported VIDAZA problem on Oct 19, 2006. Male patient, 75 years of age, weighting 182.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis What is  amyotrophic lateral sclerosis, bedridden, blood product transfusion dependent, gait disturbance, nerve injury, polyneuropathy. VIDAZA dosage: unknown. During the same period patient was treated with SIMVASTATIN. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5154593-X
VIDAZA problem was reported by a Physician from ITALY on Oct 26, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, coma hepatic, hepatic failure, hepatic necrosis, pneumonia What is  pneumonia. VIDAZA dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, TRETINOIN, DANAZOLE. Patient died.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5166006-2
Health Professional from UNITED STATES reported VIDAZA problem on Nov 16, 2006. Female patient, 47 years of age, weighting 115.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. VIDAZA dosage: 56 MG/M2 (88 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with ZOLOFT, QUINAPRIL, PRAVASTATIN, NISOLDIPINE, LORATADINE. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5166385-6
VIDAZA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: haemorrhage, pneumonia What is  pneumonia, renal failure, sepsis What is  sepsis. VIDAZA dosage: unknown. Patient was hospitalized. Patient died on 02/01/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5170131-X
Physician from UNITED STATES reported VIDAZA problem on Nov 16, 2006. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atelectasis, cardiac arrest What is  cardiac arrest, carotid artery aneurysm, carotid artery atheroma, constipation What is  constipation, electrocardiogram qt corrected interval prolonged, febrile neutropenia, hypokalaemia, hypomagnesaemia. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with AMBISOME, NORFLOXACIN, ZOFRAN, REGLAN, BENADRYL, PROTONIX, TYLENOL. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5178223-6
VIDAZA problem was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Nov 24, 2006. Female patient, 68 years of age, weighting 72.75 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: ascites, bone marrow failure, nausea, peritonitis, pneumonia What is  pneumonia, vomiting. VIDAZA dosage: 75 MG/M2 (DAILY X 7. Patient was hospitalized. Patient died on 11/18/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5178225-X
Physician from PHILIPPINES reported VIDAZA problem on Nov 23, 2006. Male patient was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: disease progression. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. Patient died.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5187668-X
VIDAZA problem was reported by a Physician from UNITED STATES on Nov 28, 2006. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bronchial obstruction, pancytopenia, pneumonia fungal, sputum culture positive. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with FORTAZ, FLEXERIL, AVODART, LOTEMAX, PROTONIX, ZOCOR, BENADRYL, TYLENOL. Patient was hospitalized. Patient died on 12/05/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5189382-3
Health Professional from FRANCE reported VIDAZA problem on Dec 01, 2006. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, bone marrow transplant, bronchopulmonary aspergillosis, condition aggravated, febrile bone marrow aplasia, pancytopenia. VIDAZA dosage: 75 MG/M2 (DAILY X 6 DAYS), SUBCUTANEOUS. During the same period patient was treated with DANATROL, ARANESP. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5191605-1
VIDAZA problem was reported by a Physician from ITALY on Dec 04, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, coagulopathy, coma hepatic, condition aggravated, hepatic failure, hepatic necrosis, hepatotoxicity, international normalised ratio increased, neutrophil count decreased. VIDAZA dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, DANAZOLE, TRETINOIN. Patient died on 10/24/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5193880-6
Physician from UNITED STATES reported VIDAZA problem on Dec 19, 2006. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: hypotension, hypoxia, interstitial lung disease, supraventricular tachycardia. VIDAZA dosage: (85 MG, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with TOPROL, FOLTX, ZOLOFT, CARDURA, ZYRTEC, ARANESP. Patient was hospitalized. Patient died on 10/23/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5195824-X
VIDAZA problem was reported by a Physician from UNITED STATES on Dec 14, 2006. Female patient, 69 years of age, weighting 158.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: asthenia, bacteria stool identified, bacterial infection, blood pressure decreased, catheter sepsis, condition aggravated, heart rate decreased, heart rate increased, nausea. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with ZOLOFT, XANAX, ASCORBIC ACID, IRON, CYANOCOBALAMIN, SPIRIVA, ALBUTEROL. Patient was hospitalized. Patient died on 12/12/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5380511-5
Physician from UNITED KINGDOM reported VIDAZA problem on June 21, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, nausea, polychromasia, red blood cell spherocytes present. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS),INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5385214-9
VIDAZA problem was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient, 68 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: abscess intestinal. VIDAZA dosage: (75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with CIPROFLOXACIN, NYSTATIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5397276-3
Physician from GERMANY reported VIDAZA problem on July 09, 2007. Male patient, 55 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis of nausea and vomiting and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: aggression. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with ONDANSETRON. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5398952-9
VIDAZA problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: pancytopenia. VIDAZA dosage: unknown. During the same period patient was treated with TYLENOL, HEPARIN, AZTREONAM, CIPROFLOXACIN, ALBUTEROL, IPRATROPIUM BROMIDE, BACTRIM, VANCOMYCIN. Patient was hospitalized. Patient died on 04/04/2006.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5402040-2
Physician from FRANCE reported VIDAZA problem on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis What is  sepsis. VIDAZA dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Vidaza Side Effects Report #5413136-3
VIDAZA problem was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 78 years of age, weighting 140.2 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, thrombocytopenia, urinary tract infection. VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, ATENOLOL. Patient was hospitalized. Patient recovered.

Submit Vidaza Side Effect Discuss Ask Vidaza Expert Compare Vidaza Side Effects Read More


Showing 1-40 of 146 Next >



Share with community: Digg Sphinn del.icio.us Facebook Mixx Google MySpace

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about prescription Vidaza Side Effects helpful. Vidaza Side Effects

, Vidaza was diagnosed with myelodysplastic syndrome and Vidaza was diagnosed with acute myeloid leukaemia and